Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022

SELL
$54.02 - $63.83 $10.8 Million - $12.8 Million
-200,046 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$55.56 - $60.79 $11.1 Million - $12.2 Million
200,046 New
200,046 $12 Million

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $243B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Taurus Asset Management, LLC Portfolio

Follow Taurus Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Taurus Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Taurus Asset Management, LLC with notifications on news.